Healthcare ServicesCompany
UCB M&A Summary
UCB has acquired 11 companies, including 4 in the last 5 years. It has also divested 7 assets.
UCB’s largest acquisition to date was in 2006, when it acquired Schwarz Pharma AG for $5.6B. It’s largest disclosed sale occurred in 2015, when it sold Kremers Urban Pharmaceuticals to Lannett Company for $1.2B. UCB has acquired in 5 different US states, and 3 countries. The Company’s most targeted sectors include life science (64%) and medical products (28%).
UCB Business Overview
Where is UCB headquartered?
UCB is headquartered in Brussels, Belgium.
What is UCB’s revenue?
UCB disclosed revenue of 5,252M EUR for 2023 and 5,517M EUR for 2022.
How many employees does UCB have?
UCB has 9,000 employees.
What sector is UCB in?
UCB is a healthcare services company.
When was UCB founded?
UCB was founded in 1928.
M&A Summary
-
M&A Total Activity18
- M&A Buy Activity11
- M&A Sell Activity7
- Total Sectors Invested 3
- Total Countries Invested 3
- M&A Buy/Sell Connections 8
- M&A Advisors 6